• Search Research Projects
  • Search Researchers
  • How to Use
  1. Back to project page

2002 Fiscal Year Final Research Report Summary

New cancer therapy by degradation of specific proteins

Research Project

Project/Area Number 13557019
Research Category

Grant-in-Aid for Scientific Research (B)

Allocation TypeSingle-year Grants
Section展開研究
Research Field Experimental pathology
Research InstitutionKyushu University

Principal Investigator

NAKAYAMA Keiichi  Kyushu University, Med. Inst. of Bioreg., Prof., 生体防御医学研究所, 教授 (80291508)

Co-Investigator(Kenkyū-buntansha) YAMASHITA Yoshinori  KYOWA HAKKO KOGYO CO.LTD., Pharma. Res. Inst. Chief Invest., 東京研究所, 主任研究員
NAKAYAMA Keiko  Tohoku Univ. Faculty of Med., Prof., 大学院・医学系研究科, 教授 (60294972)
HATAKEYAMA Shigetsugu  Kyushu University, Med. Inst. of Bioreg., Ass. Prof., 生体防御医学研究所, 助教授 (70294973)
Project Period (FY) 2001 – 2002
KeywordsMyc / Ubiquitiylation / chimeric-protein / Mad / Nedd-4
Research Abstract

We proposed to induce to degradation of specific protein by the modification of ubiquitin-ligase, Recently, it is reported that expression level of many proteins are regulated by not only transcription but degradation rate. Ubiquitin-porteasome system is one of the most useful system to regulate expression level of protein because of its specificity. On this unique point we try to create new ubiquitin-ligase to recognize and induce to degradate proteins which are toxic for our bodies.
In this project, we used oncoprotein, Myc as model protein. Because Myc is known to bind to Max, we made several chimeric proteins, Max/Nedd4, Max/b-TrCP1, Max/CHIP. Nedd-4 is a HECT-type ubiquitin-ligase. b-TrCP1 is a F-box proteins which is a component of SCF-type ubiquitin-ligase. CHIP is a U-box type ubiquitin-ligase. It was hypothesized that Myc would be bound and ubiquitylated by these chmeric proteins.
We confirmed that this artificial protein Max/CHIP bound to Myc in vitro system and also immunoprecipitation assay in vivo. The half-life of Myc reduced by overexpression of Max/CHIP protein in mammalian cells by expression vector most efficiently.
Plaque assays and colony-formation assay shown that Myc-induced transformation is inhibited by Max/CHIP chimeric protein expression.
Now, we observe the effect on whole bode. We implanted tumor cells which overexpressed Max/CHIP chimeric protein in Nude mouse to examine the effect of tumorigenesis.

  • Research Products

    (42 results)

All Other

All Publications (42 results)

  • [Publications] Minamishima, Y.A. et al.: "Recovery of liver mass without proliferation of hepatocytes after partial hepatectomy in Skp2-deficient mice"Cancer Res.. 62. 995-999 (2002)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] Yoshida, K. et al.: "Involvement of p27^<KIP1> degradation by Skp2 in the regulation of proliferation in response to wounding of corneal epithelium"Invest. Ophthalmol. Vis. Sci.. 43. 364-370 (2002)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] Koguchi, K. et al.: "Modulation of astrocyte proliferation by cyclin-dependent kinase inhibitor p27Kip1"Glia. 37. 93-104 (2002)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] Ikebe, C. et al.: "Isolation and characterization of a novel F-Box protein Pof10 in fission yeast"Biochem. Biophys. Res. Commun.. 290. 1399-1407 (2002)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] Yamanaka, A. et al.: "Multiple Skp1-related proteins in Caenorhabditis elegans. Diverse patterns of interaction with Cullins and F-box proteins"Curr. Biol.. 12. 267-275 (2002)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] Kanematsu, T. et al.: "Role of the PLC-related, catalytically inactive protein p130 in GABA_A receptor function"EMBO J.. 21. 1004-1011 (2002)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] Miyamoto A. et al.: "Increased proliferation of B cells and auto-immunity in mice lacking protein kinase Cδ"Nature. 416. 865-869 (2002)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] Masuda T. et al.: "Clinical and biological significance of S-phase kinase-associated protein 2 (Skp2) gene expression in gastric carcinoma : modulation of malignant phenotype by Skp2 overexpression, possibly via p27"Cancer Res.. 62. 3819-3825 (2002)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] Imai Y.et al.: "CHIP is associated with Parkin, a gene responsible for familial Parkinson's disease, and enhances its ubiquitin ligase activity"Mol. Cell. 10. 55-67 (2002)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] Garcia-Fernandez. et al.: "Aplidin induces the mitochondrial apoptotic pathway via oxidative stress-mediated JNK and p38 activation and protein kinase Cδ"Oncogene. 21. 7533-7544 (2002)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] Nakamichi I. et al.: "Formation of Mallory body-like Inclusions and cell death induced by deregulated expression of keratin 18"Mol. Biol. Cell. 13. 3411-3451 (2002)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] Shimoda K. et al.: "Tyk2 is required for the induction and nuclear translocation of Daxx which regulates IFN-α-induced suppression of B lymphocyte formation"J. Immunol.I. 169. 4707-4711 (2002)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] Seto Y.et al.: "Enhanced Th2 cell-mediated allergic inflammation in Tyk2-deficient mice"J. Immunol. 170. 1077-1083 (2002)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] Kaneko C. et al.: "Characterization of the mouse gene for the U-box-type ubiquitin ligase UFD2a"Biochem. Biophys. Res. Commun.. 300. 297-304 (2002)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] Tomari SI et al.: "Glomerular differentiation in p27 and p57 double-mutant metanephroi"Anat. Embryol.. 206. 31-36 (2002)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] Shirane M. et al.: "Inherent calcineurin inhibitor FKBP3B targets Bcl-2 to mitochondria and inhibits apoptosis"Nature Cell Biol.. 5. 28-63 (2002)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] Shimoda, K. et al.: "Partial impairment of interleukin-12 (IL-12) and IL-18 signaling in Tyk2-deficient mice"Blood. 99. 2094-2099 (2002)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] Ishida N. et al.: "Phosphorylation of p27^<Kip1> on serine 10 is required for its binding to CRM1 and nuclear export"J. Biol. Chem.. 277. 14355-14358 (2002)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] Hara, T. et al.: "Degradation of p27Kip1 at the G0-G1 transition mediated by a Skp2-independent ubiquitination pathway"J. Biol. Chem.. 276. 48937-48943 (2001)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] Malek, N.P.et al.: "A mouse knock-in model exposes sequential proteotytic pathways that regulate p27Kip1 in G1 and S phase"Nature. 413. 323-327 (2001)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] Nagahama, H. et al.: "Spatial and temporal expression patterns of the cyclin-dependent kinase (CDK) inhibitors p27Kip1 and p57Kip2 during mouse development"Anat. Embryol.. 203. 77-87 (2001)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] Minamishima Y. A., et. al.: "Recovery of liver mass without proliferation of hepatocytes after partial hepatectomy in Skp2-deficient mice"Cancer Res.. 62. 995-999 (2002)

    • Description
      「研究成果報告書概要(欧文)」より
  • [Publications] Yoshida K. et. al.: "Involvement of p27^<KIP1> degradation by Skp2 in the regulation of proliferation in response to wounding of comeal epithelium"Invest. Ophthalmol. Vis. Sci.. 43. 364-370 (2002)

    • Description
      「研究成果報告書概要(欧文)」より
  • [Publications] Koguchi K. et. al.: "Modulation of astrocyte proliferation by cyclin-dependent kinase inhibitor p27^<KIP1>"Glia. 37. 93-104 (2002)

    • Description
      「研究成果報告書概要(欧文)」より
  • [Publications] Ikebe C. et. al.: "Isolation and characterization of a novel F-Box protein Pof10 in fission yeast"Biochem. Biophys. Res. Commun.. 290. 1399-1407 (2002)

    • Description
      「研究成果報告書概要(欧文)」より
  • [Publications] Yamanaka A. et. al.: "Multiple Skp1-related proteins in Caenorhabditis elegans. Diverse patterns of interaction with Cullins and F-box proteins"Curr. Biol.. 12. 267-375 (2002)

    • Description
      「研究成果報告書概要(欧文)」より
  • [Publications] Kanematsu T. et. al.: "Role of the PLC-related, catalytically inactive protein p130 in GABA_A receptor function"EMBO J.. 21. 1004-1011 (2002)

    • Description
      「研究成果報告書概要(欧文)」より
  • [Publications] Miyamoto A. et. al.: "Increased proliferation of B cells and auto-immunity in mice lacking protein kinase Cδ"Nature. 416. 865-869 (2002)

    • Description
      「研究成果報告書概要(欧文)」より
  • [Publications] Masuda T. et. al.: "Clinical and biological significance of S-phase kinase-asscciated protein 2 (Skp2) gene expression in gastric carcinoma: modulation of malignant phenotype by Skp2 overexpiession, possibly via p27"Cancer Res.. 62. 3819-3825 (2002)

    • Description
      「研究成果報告書概要(欧文)」より
  • [Publications] Imai Y. et. al.: "CHIP is associated with Parkin, a gene responsible for familial Parkinson's disease, and enhances its ubiquitin ligase activity"Mol. Cell.. 10. 55-67 (2002)

    • Description
      「研究成果報告書概要(欧文)」より
  • [Publications] Garcia-Fernandez. et. al.: "Aplidin induces the mitochondrial apoptotic pathway via oxidative stress-mediated JNK and p38 activation and protein kinase Cδ"Oncogene. 21. 7533-7544 (2002)

    • Description
      「研究成果報告書概要(欧文)」より
  • [Publications] Nakamichi I. et. al.: "Formation of Mallory body-like Inclusions and cell death induced by deregulated expression of keratin 18"Mol. Biol. Cell.. 13. 3411-3451 (2002)

    • Description
      「研究成果報告書概要(欧文)」より
  • [Publications] Shimoda K. et. al.: "Tyk2 is required for the induction and nuclear translocation of Daxx which regulates IFN-α-induced suppression of B lymphocyte formation"J. Immunol.. 169. 4707-4711 (2002)

    • Description
      「研究成果報告書概要(欧文)」より
  • [Publications] Seto Y. et. al.: "Enhanced Th2 cell-mediated allergic inflammation in Tyk2-deficient mice"J. Immunol.. 170. 1077-1083 (2002)

    • Description
      「研究成果報告書概要(欧文)」より
  • [Publications] Kaneko C. et. al.: "Characterization of the mouse gene for the U-box-type ubiquitin ligase UFD2a"Biochem. Biophys. Res. Commun.. 300. 297-304 (2002)

    • Description
      「研究成果報告書概要(欧文)」より
  • [Publications] Tomari SI. et. al.: "Glomerular differentiation in p27 and p57 double-mutant metanephroi"Anat. Embryol.. 206. 31-36 (2002)

    • Description
      「研究成果報告書概要(欧文)」より
  • [Publications] Shirane M. et. al.: "Inherent calcineurin inhibitor FKBP38 targets Bcl-2 to mitochondria and inhibits apoptosis"Nature Cell Biol.. 5. 2094-2099 (2002)

    • Description
      「研究成果報告書概要(欧文)」より
  • [Publications] Shimoda K. et. al.: "Partial impairment of interleukin-12 (IL-12) and IL-18 signaling in Tyk2-deficient mice"Blood. 99. 2094-2099 (2002)

    • Description
      「研究成果報告書概要(欧文)」より
  • [Publications] Ishida N. et. al.: "Phosphorylation of p27^<Kip1> on serine 10 is required for its binding to CRM1 and nuclear export"J. Biol. Chem.. 277. 14355-14358 (2002)

    • Description
      「研究成果報告書概要(欧文)」より
  • [Publications] Hara T. et. al.: "Degradation of p27^<kip1> at the G0-G1 transition mediated by a Skp2-independent ubiquitination pathway"J. Biol. Chem.. 246. 48937-48943 (2001)

    • Description
      「研究成果報告書概要(欧文)」より
  • [Publications] Malek N. P. et. al.: "A mouse knock-in mode! exposes sequential proteolytic pathways that regulate p27^<Kip1> in G1 and S phase"Nature. 413. 323-327 (2001)

    • Description
      「研究成果報告書概要(欧文)」より
  • [Publications] Nagahama H. et. al.: "Spatial and temporal expression patterns of the cyclin-dependent kinase (CDK) inhibitors p27^<Kip1> and p57^<Kip2> during mouse development"Anat. Embryol. 203. 77-87 (2001)

    • Description
      「研究成果報告書概要(欧文)」より

URL: 

Published: 2004-04-14  

Information User Guide FAQ News Terms of Use Attribution of KAKENHI

Powered by NII kakenhi